Supraventricular tachycardia AHA recommendations for Management of Suspected Focal Atrial Tachycardia: Difference between revisions
Jump to navigation
Jump to search
Aysha Aslam (talk | contribs) |
Aysha Aslam (talk | contribs) |
||
Line 31: | Line 31: | ||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''2.'''Ibutilide may be reasonable in the acute setting to restore sinus rhythm in hemodynamically stable patients with focal AT( <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C-LD]])'' <nowiki>"</nowiki> | |bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''2.'''Ibutilide may be reasonable in the acute setting to restore sinus rhythm in hemodynamically stable patients with focal AT( <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C-LD]])'' <nowiki>"</nowiki> | ||
|- | |- | ||
|} | |||
===Management of ongoing Suspected Focal Atrial Tachycardia=== | |||
{|class="wikitable" style="width:80%" | |||
|- | |||
|colspan="1" style="text-align:center; background:LightGreen"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.'''Catheter ablation is recommended in patients with symptomatic focal AT as an alternative to pharmacological therapy ( <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B-NR]])'' <nowiki>"</nowiki> | |||
|} | |||
{|class="wikitable" style="width:80%" | |||
|- | |||
|colspan="1" style="text-align:center; background:LemonChiffon"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | |||
|- | |||
| bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.'''Oral beta blockers, diltiazem, or verapamil are reasonable for ongoing management in patients with symptomatic focal AT <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C-LD]])'' <nowiki>"</nowiki> | |||
| bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''2.'''Flecainide or propafenone can be effective for ongoing management in patients without structural heart disease or ischemic heart disease who have focal AT<nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C-LD]])'' <nowiki>"</nowiki> | |||
|} | |||
{|class="wikitable" style="width:80%" | |||
|- | |||
| colspan="1" style="text-align:center; background:LemonChiffon"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIb]] | |||
|- | |||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.'''Oral sotalol or amiodarone may be reasonable for ongoing management in patients with focal AT <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:C-LD]])'' <nowiki>"</nowiki> | |||
|} | |} | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 19:54, 25 October 2016
Supraventricular tachycardia Microchapters |
Differentiating Among the Different Types of Supraventricular Tachycardia |
---|
Differentiating Supraventricular Tachycardia from Ventricular Tachycardia |
Diagnosis |
Treatment |
2015 ACC/AHA Guideline Recommendations |
Case Studies |
Supraventricular tachycardia AHA recommendations for Management of Suspected Focal Atrial Tachycardia On the Web |
American Roentgen Ray Society Images of Supraventricular tachycardia AHA recommendations for Management of Suspected Focal Atrial Tachycardia |
Directions to Hospitals Treating Supraventricular tachycardia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
Overview
Management of Suspected Focal Atrial Tachycardia
Acute treatment of Suspected Focal Atrial Tachycardia
Class I |
"1.Intravenous beta blockers, diltiazem, or verapamil is useful for acute treatment in hemodynamically stable patients with focal AT ("(Level of Evidence: C-LD) " |
"2.Synchronized cardioversion is recommended for acute treatment in patients with hemodynamically unstable focal AT("(Level of Evidence: C-LD) " |
Class IIa |
"1.Adenosine can be useful in the acute setting to either restore sinus rhythm or diagnose the tachycardia mechanism in patients with suspected focal AT "(Level of Evidence: B-NR) " |
Class IIb |
"1.Intravenous amiodarone may be reasonable in the acute setting to either restore sinus rhythm or slow the ventricular rate in hemodynamically stable patients with focal A "(Level of Evidence:C-LD) " |
"2.Ibutilide may be reasonable in the acute setting to restore sinus rhythm in hemodynamically stable patients with focal AT( "(Level of Evidence: C-LD) " |
Management of ongoing Suspected Focal Atrial Tachycardia
Class I |
"1.Catheter ablation is recommended in patients with symptomatic focal AT as an alternative to pharmacological therapy ( "(Level of Evidence: B-NR) " |
Class IIa | |
"1.Oral beta blockers, diltiazem, or verapamil are reasonable for ongoing management in patients with symptomatic focal AT "(Level of Evidence: C-LD) " | "2.Flecainide or propafenone can be effective for ongoing management in patients without structural heart disease or ischemic heart disease who have focal AT"(Level of Evidence: C-LD) " |
Class IIb |
"1.Oral sotalol or amiodarone may be reasonable for ongoing management in patients with focal AT "(Level of Evidence:C-LD) " |